Amsterdam, Netherlands — The World Vaccine Congress Europe 2025 brought together leading vaccine developers, biotechnology companies, CROs, researchers, and industry experts from around the world. For IVANO Bioscience, the event was an excellent opportunity to reconnect with existing partners, establish new collaborations, and discuss the growing need for reliable research tools supporting vaccine development.
Throughout the congress, our team met with scientists and organizations working across a wide range of infectious diseases. These discussions highlighted an increasing demand for standardized, high-quality assay solutions that can accelerate vaccine evaluation while improving data reproducibility.
Our conversations focused on two of our core product lines:
- Pseudovirus platforms, enabling safe and reproducible neutralization studies for emerging viral pathogens.
- Detection kits, designed to simplify and standardize virology and immunology workflows.
The congress also provided valuable insight into current challenges facing vaccine developers, particularly the need for faster assay development, improved accessibility to functional antibody testing, and scalable research tools that can support both academic and industrial laboratories.
Beyond the scientific discussions, the event reinforced the importance of collaboration within the global vaccine community. Meeting face-to-face with partners and researchers allows us to better understand their evolving needs and continue developing solutions that facilitate vaccine and therapeutic research.
We would like to sincerely thank everyone who visited our booth, shared their projects, and explored potential collaborations with us. The enthusiasm and innovative work presented throughout the congress continue to inspire our team.
As we return from Amsterdam, we remain committed to our mission:
Turning complex biology into easy-to-use research tools that empower biomedical innovation.
We look forward to continuing these conversations and supporting the next generation of vaccine research worldwide.
“About IVANO Bioscience
IVANO Bioscience develops innovative research tools for virology, immunology, and gene therapy. Our portfolio includes high-quality pseudoviruses, virus-like particles (VLPs), neutralization assays, and custom assay development services designed to accelerate biomedical research while reducing experimental complexity.”
